Eckert & Ziegler SE (LON:0NZY)

Market Cap	724.00M -16.0%
Revenue (ttm)	269.09M +4.4%
Net Income	42.83M +35.7%
EPS	0.67 +36.4%
Shares Out	n/a
PE Ratio	17.44
Forward PE	16.57
Dividend	0.19 (1.66%)
Ex-Dividend Date	Jun 25, 2026

Volume	146,206
Open	13.97
Previous Close	14.05
Day's Range	13.83 - 14.01
52-Week Range	11.98 - 17.25
Beta	1.44
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 1,105
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NZY

Financial Performance

In 2025, Eckert & Ziegler SE's revenue was 311.96 million, an increase of 5.45% compared to the previous year's 295.85 million. Earnings were 48.76 million, an increase of 46.54%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error